Diabetic Gastroparesis News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Exposure study determines effective dose for diabetic gastroparesis treatment - Healio



Exposure study determines effective dose for diabetic gastroparesis treatment 
Healio
Recent study results suggest that nasal delivery of metoclopramide is effective for managing symptoms associated with acute and recurrent diabetic gastroparesis, according to a press release from Evoke Pharma. Metoclopramide (Gimoti, Evoke Pharma) is a ...

 


Diabetic Gastroparesis Treatment Industry 2017 Global Market Growth, Trends, Share and Demands Research Report - Medgadget (blog)



Last News 24
 
Diabetic Gastroparesis Treatment Industry 2017 Global Market Growth, Trends, Share and Demands Research Report 
Medgadget (blog)
Diabetic Gastroparesis Treatment Industry 2017 Market Research Report gives vital information then analytical data of Size, Share, Growth, Key Players then forecast to 2022. Furthermore it provides development trends and marketing channels analysis.
Global Diabetic Gastroparesis Treatment Market 2017- Evoke Pharma, Medtronic Plc. The Gulf Feed

all 3 news articles » 


Diabetic Gastroparesis Treatment Global Market 2017: (Janssen Global Services, LLC, Evoke Pharma, Cardinal Health) - Newsient (blog)



Diabetic Gastroparesis Treatment Global Market 2017: (Janssen Global Services, LLC, Evoke Pharma, Cardinal Health) 
Newsient (blog)
HTF MI published a new industry research that focuses on Diabetic Gastroparesis Treatment market and delivers in-depth market analysis and future prospects of Global Diabetic Gastroparesis Treatment market. The study covers significant data which makes ...

 


Your Good Health: Stomach unable to empty properly - Times Colonist



Times Colonist
 
Your Good Health: Stomach unable to empty properly 
Times Colonist
Most cases I see are in people with diabetes, but it can happen after surgery or with severe neurological diseases, such as multiple sclerosis. Often, we never find a cause for gastroparesis. It has been described following a viral infection, such as ...

 


Woman finds hope despite crippling condition - Florida Today



Florida Today
 
Woman finds hope despite crippling condition 
Florida Today
The cause of gastroparesis is unknown, but diabetes seems to have a connection with the condition. ?Seventy percent of people with gastroparesis are diabetics, but I'm not one of them,? said Miles. Since May, Miles has faced several intestinal ...

 


Diabetic Gastroparesis Market is Estimated to be Valued at US$ 3769.3 Mn by 2024 - MilTech



Diabetic Gastroparesis Market is Estimated to be Valued at US$ 3769.3 Mn by 2024 
MilTech
According to the latest market report published by Persistence Market Research titled ?Diabetic Gastroparesis Treatment Market: Global Industry Analysis and Forecast, 2016 ? 2024?, revenue from the global diabetic gastroparesis treatment market is ...

and more » 


Gastroparesis is a stomach that is too slow to empty - STLtoday.com



Gastroparesis is a stomach that is too slow to empty 
STLtoday.com
Most cases I see are in people with diabetes, but it can happen after surgery or with severe neurological diseases, such as multiple sclerosis. Often, we never find a cause for gastroparesis. It has been described following a viral infection, such as ...

and more » 


Evoke Pharma Signs Commercial Agreement with Thermo Fisher Scientific - GlobeNewswire (press release)



BangaloreWeekly
 
Evoke Pharma Signs Commercial Agreement with Thermo Fisher Scientific 
GlobeNewswire (press release)
The Company is developing Gimoti, a metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent gastroparesis in women with diabetes mellitus. Diabetic gastroparesis is a GI disorder afflicting millions of sufferers ...
7 Breakout Stocks for 2018 Zacks.com
Thermo Fisher Scientific Inc - TMO - Stock Price Today - Zacks Zacks Investment Research
SEC FORM 4 - SEC.gov SEC.gov

all 144 news articles » 


Evoke Pharma Reports Third Quarter 2017 Results and Highlights - Markets Insider



Evoke Pharma Reports Third Quarter 2017 Results and Highlights 
Markets Insider
We remain confident that Gimoti holds significant potential to bring a new treatment option to those suffering from acute and recurrent diabetic gastroparesis." Mr. Gonyer continued, ?As we prepare to submit our 505(b)(2) NDA to FDA in the first ...
Evoke Pharma's (NASDAQ:EVOK) Buy Rating Reiterated at FBR & Co Dispatch Tribunal
Somewhat Favorable Press Coverage Somewhat Unlikely to Impact Evoke Pharma (EVOK) Share Price TrueBlueTribune
Evoke Pharma Cmn (NASDAQ:EVOK) Experiences Lighter than ... Modern Readers

all 7 news articles » 


Evoke Pharma Announces Positive Topline Results from ... - GlobeNewswire (press release)